Drug Description in Trials / DrugBank / KEGG DRUG
Search results
No. | 薬物名(臨床試験情報から抽出) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 |
---|---|---|---|---|---|---|
1 | Abatacept, rituximab or tocilizumab (Rituximab (genetical recombination) (JAN)) | 3件: Abatacept Abatacept,Rituximab, Tocilizumab | 3件: Tocilizumab
Tocilizumab
,Rituximab (Rituximab (genetical recombination) (JAN)), Abatacept 💬 | 4件: CD80 CD80,CD86, IL6R, MS4A1 💬 | 25件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬 | 1件: 46 46 💬 |
2 | ABP 798 - Biosimilar to rituximab (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
3 | ABP 798 Biosimilar to Rituximab (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
4 | Administration of rituximab and methylprednisolone (Rituximab (genetical recombination) (JAN)) | 2件: Methylprednisolone Methylprednisolone,Rituximab | 2件: Methylprednisolone
Methylprednisolone
,Rituximab (Rituximab (genetical recombination) (JAN)) 💬 | 2件: MS4A1 MS4A1,NR3C1 💬 | 2件: Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | 1件: 51 51 💬 |
5 | Alemtuzumab and Rituximab (Rituximab (genetical recombination) (JAN)) | 2件: Alemtuzumab Alemtuzumab,Rituximab | 2件: Alemtuzumab
Alemtuzumab
,Rituximab (Rituximab (genetical recombination) (JAN)) 💬 | 2件: CD52 CD52,MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 60 60 💬 |
6 | Alemtuzumab, Rituximab (Rituximab (genetical recombination) (JAN)) | 2件: Alemtuzumab Alemtuzumab,Rituximab | 2件: Alemtuzumab
Alemtuzumab
,Rituximab (Rituximab (genetical recombination) (JAN)) 💬 | 2件: CD52 CD52,MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 63 63 💬 |
7 | Belimumab in SLE patients / Rituximab in RA patients (Rituximab (genetical recombination) (JAN)) | 2件: Belimumab Belimumab,Rituximab | 2件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)),Belimumab 💬 | 2件: MS4A1 MS4A1,TNFSF13B 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 2件: 46 46, 49 💬 |
8 | Bendamustine, Rituximab (Rituximab (genetical recombination) (JAN)) | 2件: Bendamustine Bendamustine,Rituximab | 2件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)),Bendamustine 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 61 61 💬 |
9 | Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine (Rituximab (genetical recombination) (JAN)) | 3件: Azathioprine Azathioprine,Dexamethasone, Rituximab | 3件: Azathioprine
Azathioprine
,Dexamethasone , Rituximab (Rituximab (genetical recombination) (JAN)) 💬 | 2件: MS4A1 MS4A1,NR3C1 💬 | 2件: Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | 1件: 35 35 💬 |
10 | Combination of Rituximab (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 63 63 💬 |
11 | Combination of Rituximab with subcutaneous belimumab (Rituximab (genetical recombination) (JAN)) | 2件: Belimumab Belimumab,Rituximab | 2件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)),Belimumab 💬 | 2件: MS4A1 MS4A1,TNFSF13B 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 63 63 💬 |
12 | Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 85 85 💬 |
13 | Cyclophosphamide/Rituximab (Rituximab (genetical recombination) (JAN)) | 2件: Cyclophosphamide Cyclophosphamide,Rituximab | 3件: Cyclophosphamide
Cyclophosphamide
,Rituximab (Rituximab (genetical recombination) (JAN)), Cyclophosphamide 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬 |
14 | Dexamethasone and Rituximab (Rituximab (genetical recombination) (JAN)) | 2件: Dexamethasone Dexamethasone,Rituximab | 2件: Dexamethasone
Dexamethasone
,Rituximab (Rituximab (genetical recombination) (JAN)) 💬 | 2件: MS4A1 MS4A1,NR3C1 💬 | 2件: Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 💬 |
15 | Double-Blind Rituximab (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 51 51 💬 |
16 | Dr. Reddy’s Rituximab (DRL_RI) 100mg (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
17 | Dr. Reddy’s Rituximab (DRL_RI) 500mg (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
18 | Eltrombopag combining rituximab (Rituximab (genetical recombination) (JAN)) | 2件: Eltrombopag Eltrombopag,Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 63 63 💬 |
19 | Etanercepet, Rituximab, Abatacept, Tocilizumab, Sarilumab (Rituximab (genetical recombination) (JAN)) | 4件: Abatacept Abatacept,Rituximab, Sarilumab, Tocilizumab | 4件: Tocilizumab
Tocilizumab
,Rituximab (Rituximab (genetical recombination) (JAN)), Abatacept , Sarilumab 💬 | 4件: CD80 CD80,CD86, IL6R, MS4A1 💬 | 25件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬 | 1件: 46 46 💬 |
20 | Experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab) (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 222 222 💬 |
21 | GP2013 - A Proposed biosimilar rituximab (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
22 | IDEC-C2B8 (rituximab) (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
23 | Immunosuppressive treatment (eg, rituximab) (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 64 64 💬 |
24 | Individualized dose of rituximab (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 49 49 💬 |
25 | Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab (Rituximab (genetical recombination) (JAN)) | 12件: Acetate Acetate,Alemtuzumab, Cladribine, Dimethyl fumarate, Fingolimod, Glatiramer, Natalizumab, Ocrelizumab, Ofatumumab, Ponesimod, Rituximab, Teriflunomide | 10件: Cladribine
Cladribine
,Alemtuzumab , Rituximab (Rituximab (genetical recombination) (JAN)), Dimethyl fumarate , Ocrelizumab , Natalizumab , Ofatumumab , Fingolimod , Teriflunomide , Ponesimod 💬 | 7件: CD52 CD52,DHODH, ITGA4, KEAP1, MS4A1, RRM1, S1PR1 💬 | 30件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Biosynthesis of cofactors, Cell adhesion molecules, Chemical carcinogenesis - reactive oxygen species, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Glutathione metabolism, Hematopoietic cell lineage, Hepatocellular carcinoma, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, PI3K-Akt signaling pathway, Parkinson disease, Pathways in cancer, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, Ubiquitin mediated proteolysis, Yersinia infection 💬 | 1件: 13 13 💬 |
26 | Intravenous Rituximab (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 66 66 💬 |
27 | MabionCD20 (candidate biosimilar to rituximab) (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
28 | MabThera (Rituximab) (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 4件: 13 13, 46, 49, 53 💬 |
29 | Mabthera or biosimilar Rituximab (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 61 61 💬 |
30 | Mabthera or biosimilar rituximab product (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬 |
31 | MabThera® (rituximab) (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
32 | Originator rituximab - Rituxan ® or MabThera ® (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
33 | Perfusion of treatment Rituximab (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬 |
34 | Prednisone, low dose rituximab (Rituximab (genetical recombination) (JAN)) | 2件: Prednisone Prednisone,Rituximab | 2件: Prednisone
Prednisone
,Rituximab (Rituximab (genetical recombination) (JAN)) 💬 | 2件: MS4A1 MS4A1,NR3C1 💬 | 2件: Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | 1件: 61 61 💬 |
35 | RhTPO in combination with Rituximab (Rituximab (genetical recombination) (JAN)) | 2件: Recombinant Human Thrombopoietin Recombinant Human Thrombopoietin,Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 63 63 💬 |
36 | Rituxan (INN: Rituximab), brand name in the United States (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
37 | Rituxan (INN: Rituximab), brand name in the US (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
38 | Rituxan (rituximab) (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 49 49 💬 |
39 | Rituxan® (rituximab) (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
40 | RITUXIMAB (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 48件: 11 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
41 | Rituximab (anti-CD20) (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 53 53 💬 |
42 | Rituximab (Arm A) (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 43 43, 44 💬 |
43 | Rituximab (Arm B) (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 43 43, 44 💬 |
44 | Rituximab (EU) (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
45 | Rituximab (genetical recombination) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 14 14 💬 |
46 | Rituximab (MABTHERA® or RITUXAN®). (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 35 35, 61 💬 |
47 | Rituximab (Mabthera®) (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 61 61 💬 |
48 | Rituximab (Rituxan) (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 11 11 💬 |
49 | Rituximab (RTX) and Azathioprine (AZA) (Rituximab (genetical recombination) (JAN)) | 2件: Azathioprine Azathioprine,Rituximab | 2件: Azathioprine
Azathioprine
,Rituximab (Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 65 65 💬 |
50 | Rituximab (US) (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
51 | Rituximab - MabThera (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
52 | Rituximab 1g IV (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 162 162 💬 |
53 | Rituximab [MabThera/Rituxan] (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 46 46, 63 💬 |
54 | Rituximab [MabThera] (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
55 | Rituximab and Cyclophosphamide IV (Rituximab (genetical recombination) (JAN)) | 2件: Cyclophosphamide Cyclophosphamide,Rituximab | 3件: Cyclophosphamide
Cyclophosphamide
,Rituximab (Rituximab (genetical recombination) (JAN)), Cyclophosphamide 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 35 35 💬 |
56 | Rituximab and Hyaluronidase Human (Rituximab (genetical recombination) (JAN)) | 2件: Hyaluronidase Hyaluronidase,Rituximab | 4件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)),Hyaluronidase , Hyaluronidase , Hyaluronidase 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 331 331 💬 |
57 | Rituximab combined with Omalizumab (Rituximab (genetical recombination) (JAN)) | 2件: Omalizumab Omalizumab,Rituximab | 2件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)),Omalizumab 💬 | 2件: FCER1A FCER1A,MS4A1 💬 | 5件: Asthma Asthma, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬 | 1件: 162 162 💬 |
58 | Rituximab combined with tacrolimus induction + rituximab maintenance (Rituximab (genetical recombination) (JAN)) | 2件: Rituximab Rituximab,Tacrolimus | 3件: Tacrolimus
Tacrolimus
,Rituximab (Rituximab (genetical recombination) (JAN)), Tacrolimus 💬 | 6件: MS4A1 MS4A1,PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 34件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 222 222 💬 |
59 | Rituximab combined with tacrolimus induction + tacrolimus maintenance (Rituximab (genetical recombination) (JAN)) | 2件: Rituximab Rituximab,Tacrolimus | 3件: Tacrolimus
Tacrolimus
,Rituximab (Rituximab (genetical recombination) (JAN)), Tacrolimus 💬 | 6件: MS4A1 MS4A1,PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 34件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 222 222 💬 |
60 | Rituximab Infusion (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 13 13, 222 💬 |
61 | Rituximab IT (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬 |
62 | Rituximab IV (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬 |
63 | Rituximab konsentrat til infusjonsvaeske oppløsning 10 mg/ml (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬 |
64 | Rituximab MabThera (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
65 | Rituximab, Cyclophosphamide, and Corticosteroids (Rituximab (genetical recombination) (JAN)) | 2件: Cyclophosphamide Cyclophosphamide,Rituximab | 3件: Cyclophosphamide
Cyclophosphamide
,Rituximab (Rituximab (genetical recombination) (JAN)), Cyclophosphamide 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 222 222 💬 |
66 | Rituximab, Mabthera (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 53 53 💬 |
67 | Rituximab, MTX, folic acid (Rituximab (genetical recombination) (JAN)) | 2件: Folic acid Folic acid,Rituximab | 2件: Folic acid
Folic acid
,Rituximab (Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
68 | Rituximab, observational study amon patients with active RA (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
69 | Rituximab-EU+ Rituximab-Pfizer x 2 Courses (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
70 | Rituximab-Pfizer (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
71 | Rituximab-Pfizer (PF-05280586) x 3 courses (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
72 | Rituximab-US + Rituximab-Pfizer x 2 Courses (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
73 | Rituximab/ Mabthera (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 271 271 💬 |
74 | SAIT101 (proposed rituximab biosimilar) (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
75 | SAIT101 (rituximab biosimilar) (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬 |
76 | Standard dose of rituximab (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 49 49 💬 |
77 | The Standard Steroid Treatment, Plasma Exchange and rituximab (Rituximab (genetical recombination) (JAN)) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
(Rituximab (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 85 85 💬 |